Trupanion (NASDAQ:TRUP) Price Target Raised to $45.00

Trupanion (NASDAQ:TRUP) had its price target boosted by Northland Securities from $35.00 to $45.00 in a research report report published on Thursday, Benzinga reports. They currently have a market perform rating on the financial services provider’s stock.

A number of other equities analysts also recently commented on TRUP. Stifel Nicolaus reissued a hold rating and set a $30.00 price objective (up from $22.00) on shares of Trupanion in a research report on Friday, August 9th. Piper Sandler boosted their price objective on Trupanion from $30.00 to $38.00 and gave the stock a neutral rating in a research report on Friday, August 9th. Evercore ISI upgraded Trupanion to a strong-buy rating in a research note on Friday, August 9th. Finally, William Blair initiated coverage on Trupanion in a research note on Friday, July 19th. They set an outperform rating for the company. Four analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of Moderate Buy and an average target price of $39.00.

Trupanion Stock Performance

Shares of Trupanion stock opened at $42.80 on Thursday. Trupanion has a one year low of $19.14 and a one year high of $49.14. The company has a market cap of $1.80 billion, a PE ratio of -66.88 and a beta of 1.74. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.63 and a current ratio of 1.63. The business has a 50-day simple moving average of $40.56 and a 200-day simple moving average of $31.75.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Thursday, August 8th. The financial services provider reported ($0.14) EPS for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.04. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. The business had revenue of $314.80 million during the quarter, compared to the consensus estimate of $309.33 million. During the same period in the previous year, the company posted ($0.33) earnings per share. The business’s revenue for the quarter was up 16.3% on a year-over-year basis. On average, equities research analysts forecast that Trupanion will post -0.37 EPS for the current fiscal year.

Insider Buying and Selling

In other Trupanion news, CEO Margaret Tooth sold 7,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the sale, the chief executive officer now owns 99,984 shares in the company, valued at $4,647,256.32. The sale was disclosed in a document filed with the SEC, which is available through this link. In other Trupanion news, CEO Margaret Tooth sold 7,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the sale, the chief executive officer now owns 99,984 shares in the company, valued at $4,647,256.32. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Fawwad Qureshi sold 624 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $46.54, for a total value of $29,040.96. The disclosure for this sale can be found here. Insiders sold a total of 8,764 shares of company stock worth $405,238 over the last 90 days. 5.50% of the stock is owned by insiders.

Institutional Investors Weigh In On Trupanion

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. EP Wealth Advisors LLC purchased a new stake in shares of Trupanion during the second quarter worth approximately $294,000. AQR Capital Management LLC raised its stake in shares of Trupanion by 173.8% during the second quarter. AQR Capital Management LLC now owns 43,553 shares of the financial services provider’s stock worth $1,280,000 after purchasing an additional 27,644 shares during the last quarter. Marshall Wace LLP raised its stake in shares of Trupanion by 11.9% during the second quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock worth $32,181,000 after purchasing an additional 116,496 shares during the last quarter. Public Sector Pension Investment Board raised its stake in shares of Trupanion by 7.3% during the second quarter. Public Sector Pension Investment Board now owns 79,555 shares of the financial services provider’s stock worth $2,339,000 after purchasing an additional 5,405 shares during the last quarter. Finally, Dalton Investments Inc. purchased a new stake in shares of Trupanion during the second quarter worth approximately $1,029,000.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.